Literature DB >> 15168660

Role of VLDL receptor in the process of foam cell formation.

Shen Qu1, Fan Wu, Jun Tian, Yinghong Li, Yan Wang, Yuzhe Wang, Yiqiang Zong.   

Abstract

The role of very low density lipoprotein receptor (LVLDR) in the process of foam cell formation was investigated. After the primary cultured mouse peritoneal macrophages were incubated with VLDL, beta-VLDL or low density lipoprotein (LDL), respectively for 24 h and 48 h, foam cells formation was identified by oil red O staining and cellular contents of triglyceride (TG) and total cholesterol (TC) were determined. The mRNA levels of LDLR, LDLR related protein (ILRP) and VLDLR were detected by semi-quantitative RT-PCR. The results demonstrated that VLDL, beta-VLDL and LDL could increase the contents of TG and TC in macrophages. Cells treated with VLDL or beta-VLDL showed markedly increased expression of VLDLR and decreased expression of LDLR, whereas LRP was up-regulated slightly. For identifying the effect of VLDL receptor on cellular lipid accumulation, ldl-A7-VR cells, which expresses VLDLR and trace amount of LRP without functional LDLR, was used to incubate with lipoproteins for further examination. The results elucidated that the uptake of triglyceride-rich lipoprotein mediated by VLDLR plays an important role in accumulation of lipid and the formation of foam cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15168660     DOI: 10.1007/bf02830692

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  6 in total

1.  Rapid isolation of large amount of plasma VLDL and LDL by a two step ultracentrifugation.

Authors:  C B Wang; Y M Feng; Y Q Zong; Y Z Deng; Z C Feng
Journal:  J Tongji Med Univ       Date:  1995

2.  Expression of very low density lipoprotein receptor mRNA in circulating human monocytes: its up-regulation by hypoxia.

Authors:  K Nakazato; T Ishibashi; K Nagata; Y Seino; Y Wada; T Sakamoto; R Matsuoka; T Teramoto; M Sekimata; Y Homma; Y Maruyama
Journal:  Atherosclerosis       Date:  2001-04       Impact factor: 5.162

3.  Mouse very low-density lipoprotein receptor (VLDLR): gene structure, tissue-specific expression and dietary and developmental regulation.

Authors:  O Tiebel; K Oka; K Robinson; M Sullivan; J Martinez; M Nakamuta; K Ishimura-Oka; L Chan
Journal:  Atherosclerosis       Date:  1999-08       Impact factor: 5.162

4.  Expression of LDL receptor, VLDL receptor, LDL receptor-related protein, and scavenger receptor in rabbit atherosclerotic lesions: marked induction of scavenger receptor and VLDL receptor expression during lesion development.

Authors:  T P Hiltunen; J S Luoma; T Nikkari; S Ylä-Herttuala
Journal:  Circulation       Date:  1998-03-24       Impact factor: 29.690

Review 5.  Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome.

Authors:  S M Grundy
Journal:  Am J Cardiol       Date:  1998-02-26       Impact factor: 2.778

6.  Transcription factors CCAAT/enhancer-binding protein beta and nuclear factor-Y bind to discrete regulatory elements in the very low density lipoprotein receptor promoter.

Authors:  R Kreuter; A K Soutar; D P Wade
Journal:  J Lipid Res       Date:  1999-03       Impact factor: 5.922

  6 in total
  3 in total

1.  Function and significance of very low density lipoprotein receptor subtype II.

Authors:  Jun Tian; Hao Bi; Yinghong Li; Pu Yang; Yiqiang Zong; Yu Wang; Shen Qu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2005

2.  Up-regulation of VLDL receptor expression and its signaling pathway induced by VLDL and beta-VLDL.

Authors:  Zhiguo Liu; He Li; Yinghong Li; Yan Wang; Yiqiang Zong; Youmei Feng; Zongchen Feng; Yaozu Deng; Shen Qu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2009-02-18

3.  A Subregion of Reelin Suppresses Lipoprotein-Induced Cholesterol Accumulation in Macrophages.

Authors:  Emmanuel U Okoro; Hongfeng Zhang; Zhongmao Guo; Fang Yang; Carlie Smith; Hong Yang
Journal:  PLoS One       Date:  2015-08-28       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.